LEXINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to welcome Dr. Dafni Bika to the Company’s Board of Directors (the “Board”). “We are extremely pleased to welcome Dr. Bika to our Board of Directors,” said Robert Spignesi, President and C ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission File Numbe ...

Rapid Micro Biosystems (RPID) Q1 2025 Earnings Call May 09, 2025 08:30 AM ET Company Participants Michael Beaulieu - Vice President of Investor Relations & Corporate CommunicationsSean Wirtjes - Chief Financial OfficerDan Arias - Managing DirectorRobert Spignesi - CEO, President & DirectorPaul Knight - Managing DirectorChad Wiatrowski - VP - Equity Research Operator Thank you for standing by. My name is RG, and I will be your conference operator today. At this time, I would like to welcome everyone to the R ...

Rapid Micro Biosystems (RPID) Q1 2025 Earnings Call May 09, 2025 08:30 AM ET Company Participants Michael Beaulieu - Vice President of Investor Relations & Corporate CommunicationsSean Wirtjes - Chief Financial OfficerDan Arias - Managing DirectorRobert Spignesi - CEO, President & DirectorPaul Knight - Managing DirectorChad Wiatrowski - VP - Equity Research Operator Thank you for standing by. My name is RG, and I will be your conference operator today. At this time, I would like to welcome everyone to the R ...

Rapid Micro Biosystems (RPID) Q1 2025 Earnings Call May 09, 2025 08:30 AM ET Speaker0 Thank you for standing by. My name is RG, and I will be your conference operator today. At this time, I would like to welcome everyone to the Rapid Micro Biosystems First Quarter twenty twenty five Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. Thank you. I would now like to turn the call over to Mike Bu ...

Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.70%. A quarter ago, it was expected that this company would post a loss of $0.24 per share when it actually produced a loss of $0.22, delivering a surprise of 8.33%.Over the last four quarters, the company h ...

Exhibit 99.1 Rapid Micro Biosystems Reports First Quarter 2025 Financial Results Lexington, MA, May 9, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2025. "We delivered strong revenue growth of 28% in the first q ...

Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.Announced a global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates in the U.S. as MilliporeSigma (“MilliporeSigma ...

LEXINGTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2025 financial results prior to the market open on Friday, May 9, 2025. In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET ...

Core Points - Rapid Micro Biosystems, Inc. announced the grant of equity awards to new employees as part of its Inducement Plan, including 50,000 restricted stock units (RSUs) and 250,000 stock options [1][4] - The stock options have an exercise price of $2.27 per share, with a vesting schedule that includes 25% vesting on the first anniversary and monthly vesting thereafter [2] - The RSUs will vest annually over a three-year period, with one-third vesting on each anniversary of their grant dates [3] Company Overview - Rapid Micro Biosystems is a life sciences technology company that provides automation solutions for the manufacturing and release of healthcare products, including biologics, vaccines, and sterile injectables [5] - The company's flagship product, the Growth Direct system, modernizes microbial quality control testing workflows in pharmaceutical manufacturing, enhancing efficiency, accuracy, and compliance [5] - The company is headquartered in Lexington, Massachusetts, with manufacturing in Lowell, Massachusetts, and additional locations in Switzerland, Germany, and the Netherlands [5]